Journals / Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi / 2022 / Cilt: 5 - Sayı: 3

Reporting of Randomized Controlled Studies in Nursing Research and the Use of Non-pharmacological CONSORT Extension

Hemşirelik Araştırmalarında Randomize Kontrollü Çalışmaların Raporlanması ve Non-farmakolojik CONSORT Uzantısının Kullanımı

Pages
433–439
Publication Date
2022-12-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it is aimed to emphasize the importance of reporting randomized controlled studies in the field of nursing according to the Consolidated Standards of Reporting Trials system and to raise awareness about the use of the nonpharmacological CONSORT extension in nursing research.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The most crucial principle of evidence-based medicine; evaluating available evidence, obtaining the best evidence, and making a decision based on that evidence.
📊
Key Findings & Data:In recent years, there has been an increase in the number of experimentally designed and published studies in nursing.
💡
Conclusion & Impact:In this review, it is aimed to emphasize the importance of reporting randomized controlled studies in the field of nursing according to the Consolidated Standards of Reporting Trials system and to raise awareness about the use of the nonpharmacological CONSORT extension in nursing research.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kanıta dayalı hemşirelik · randomize kontrollü çalışma · hemşirelik araştırması

Abstract

The most crucial principle of evidence-based medicine; evaluating available evidence, obtaining the best evidence, and making a decision based on that evidence. The basis of evidence-based nursing practices; the production of the best available evidence in the field of nursing, the use of this evidence in nursing care by integrating with clinical expertise and patient preferences. In this context, randomized controlled experimental designs are directly related and indispensable for producing evidence and informing nurses about clinical nursing decisions. In recent years, there has been an increase in the number of experimentally designed and published studies in nursing. However, limitations remain regarding the use of reporting systems that provide a complete, open, and transparent presentation of randomized controlled experimental designs' methodology and findings. For this reason, it is crucial to report randomized controlled studies according to internationally validated checklists in nursing studies to determine reporting standards and to avoid systematic reporting errors. In this review, it is aimed to emphasize the importance of reporting randomized controlled studies in the field of nursing according to the Consolidated Standards of Reporting Trials system and to raise awareness about the use of the nonpharmacological CONSORT extension in nursing research.

Özet

Kanıta dayalı tıbbın en önem ilkesi; mevcut kanıtların değerlendirilmesi, en iyi kanıtlara ulaşılması ve bu kanıtlar doğrultusunda karar verilmesidir. Kanıta dayalı hemşirelik uygulamalarının temelini ise; hemşirelik alanındaki en iyi kanıtların üretilmesi, bu kanıtların klinik uzmanlık ve hasta tercihleri ile entegrasyonun sağlanarak hemşirelik bakımında kullanımı oluşturmaktadır. Bu kapsamda randomize kontrollü deneysel tasarımlar kanıtların üretilmesi ve hemşireleri klinik hemşirelik kararları konusunda bilgilendirilmesiyle doğrudan ilişkili ve vazgeçilemez konumdadır. Son yıllarda, hemşirelik alanında deneysel olarak tasarlanan ve yayınlanan çalışmaların sayısında artış görülmektedir. Ancak randomize kontrollü deneysel tasarımların metodolojisini, bulgularını eksiksiz, açık ve şeffaf bir şekilde sunulmasını sağlayan raporlama sistemlerinin kullanımıyla ilgili sınırlılıklar devam etmektedir. Bu nedenle randomize kontrollü çalışmaların raporlama standartlarını belirlemek, sistematik raporlama hatalarından kaçınmak için, hemşirelik araştırmalarının uluslararası geçerliliği olan kontrol listelerine göre raporlandırılması önemlidir. Bu derlemede, hemşirelik alanında randomize kontrollü çalışmaların Konsolide Raporlama Denemeleri Bildirimi (CONSORT) sistemine göre raporlanmasının önemini vurgulamak ve hemşirelik araştırmalarında non-farmakolojik CONSORT uzantısının kullanımı hakkında farkındalık oluşturmak amaçlanmıştır.

🔖

Cite This Article

DOĞAN, A., KOYU, H. Ö., BİLGİLİ, N. (2022). Reporting of Randomized Controlled Studies in Nursing Research and the Use of Non-pharmacological CONSORT Extension. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi, Cilt: 5 - Sayı: 3, 433–439. https://ajindex.com/articles/870226

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Akın B, Kocoglu D. (2017). Randomize kontrollü deneyler. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi, 4, 1, 73-92.
  2. Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD. (2013). Reporting of patient-reported outcomes in randomized trials: The consort pro extension. The Journal of the American Medical Association, 309, 8, 814-822.
  3. Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. (2017). Consort statement for randomized trials of nonpharmacologic treatments: A 2017 update and a consort extension for nonpharmacologic trial abstracts. Annals of Internal Medicine, 167, 1, 40-47.
  4. Boutron I, Guittet L, Estellat C, Moher D, Hrobjartsson A, Ravaud P. (2007). Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. Public Library of Science Medicine, 4, 2, 61. Campbell MK, Piaggio G, Elbourne DR, Altman DG; CONSORT Group. (2012). Consort 2010 statement: Extension to cluster randomised trials. British Medical Journal. 345, 5661. Chan AW, Altman DG. (2005). Epidemiology and reporting of randomised trials published in pubmed journals. The Lancet, 365, 9465, 1159-1162.
  5. Cheng CW, Wu TX, Shang HC, Li YP, Altman DG, Moher D, Bian ZX, CONSORT-CHM Formulas 2017
  6. Group (2017). Consort extension for chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration. Annals of Internal Medicine, 167, 2, 112-121.
  7. DiCenso A, Guyatt G, Ciliska D. (2005). Evidence-based nursing: A guide to clinical practice. Elsevier Health Sciences, p. 508-509.
  8. Djulbegovic B, Guyatt GH. (2017). Progress in evidence-based medicine: A quarter century on. The Lancet, 390, 10092, 415- 423. Dwan K, Li T, Altman DG, Elbourne D. (2019). Consort 2010 statement: Extension to randomised crossover trials. British Medical Journal, 36, 6, l4378. Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. (2016). CONSORT 2010 statement: Extension to randomised pilot and feasibility trials. British Medical Journal, 355, 5239. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. (2006). Reporting randomized, controlled trials of herbal interventions: An elaborated Consort statement. Annals of Internal Medicine, 144, 5, 364-367.
  9. Glasgow RE, Green LW, Klesges LM, Abrams DB, Fisher EB, Goldstein MG, et al. (2006). External validity: We need to do more. Annals of Behavioral Medicine, 31, 2, 105-108.
  10. Gonella S, Di Giulio P, Pales A, Dimonte, V, Campagna, S. (2019). Randomized controlled trials and quasi‐ experimental studies publis